Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120

Nature Medicine

Volumn 11, Issue 1, 2005, Pages 90-94

  Hirasawa, Akira ^a,b,c   Tsumaya, Keiko ^a   Awaji, Takeo ^d   Katsuma, Susumu ^b   Adachi, Tetsuya ^b   Yamada, Masateru ^a   Sugimoto, Yukihiko ^b   Miyazaki, Shunichi ^d   Tsujimoto, Gozoh ^b,c  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; FATTY ACID; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; INSULIN; POLYPEPTIDE; UNSATURATED FATTY ACID;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET; ENERGY RESOURCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ANIMALS; FATTY ACIDS, NONESTERIFIED; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INTESTINAL MUCOSA; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER;

EID: 13444263540     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1168     Document Type: Article

References (30)

1. Zimmet, P., Alberti, K.G. & Shaw, J. Global and societal implications of the diabetes epidemic. Nature 414, 782-787 (2001).
2. Gadsby, R. Epidemiology of diabetes. Adv. Drug. Deliv. Rev. 54, 1165-1172 (2002).
3. Jovanovic, L. & Gondos, B. Type 2 diabetes: the epidemic of the new millennium. Ann. Clin. Lab. Sci. 29, 33-42 (1999).
4. Creutzfeldt, W. & Ebert, R. New developments in the incretin concept. Diabetologia 28, 565-573 (1985).
5. Kieffer, T.J. & Habener, J.F. The glucagon-like peptides. Endocr. Rev. 20, 876-913 (1999).
6. Kreymann, B., Williams, G., Ghatei, M.A. & Bloom, S.R. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2, 1300-1304 (1987).
7. Nunez, E.A. Biological complexity is under the 'strange attraction' of non-esterified fatty acids. Prostaglandins. Leukot. Essent. Fatty Acids 57, 107-110 (1997).
8. Thomsen, C., Storm, H., Holst, J.J. & Hermansen, K. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am. J. Clin. Nutr. 77, 605-611 (2003).
9. MacDonald, P.E. et al. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 51 Suppl 3, S434-S442 (2002).
10. Drucker, D.J. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol. Endocrinol. 17, 161-171 (2003).
11. Fredriksson, R., et al. Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett. 554, 381-388 (2003).
12. Tsao, P., Cao, T. & von Zastrow, M. Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends. Pharmacol. Sci. 22, 91-96 (2001).
13. Ding, G.J., et al. Characterlization and quantitation of NF-κB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α. Development and use of a high capacity fluorescence cytometric system. J. Biol. Chem. 273, 28897-28905 (1998).
14. Milligan, G., Marshall, F. & Rees, S. G16 as a universal G protein adapter: implications for agonist screening strategies. Trends. Pharmacol. Sci. 17, 235-237 (1996).
15. Vilsboll, T., et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 88, 2706-2713. (2003).
16. Holst, J.J. & Orskov, C. Incretin hormones - an update. Scand. J. Clin. Lab. Invest. Suppl.234, 75-85 (2001).
17. Gulmbaud, R., et al. Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas. 14, 76-82 (1997).
18. 2+ in two enteroendocrine cell lines, STC-1 and GLUTag. J. Physiol. 528, 165-176 (2000).
19. Itoh, Y., et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422, 173-176 (2003).
20. Cao, X., et al. Aberrant regulation of human intestinal proglucagon gene expression in the NC1-H716 cell line. Endocrinology 144, 2025-2033 (2003).
21. Reimer, R.A., et al. A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology 142, 4522-4528 (2001).
22. Trogan, E., et al. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA 99, 2234-2239 (2002).
23. Briscoe, C.P., et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278, 11303-11311 (2003).
24. Brown, A.J., et al. The Drphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312-11319 (2003).
25. Nilsson, N.E., Kotarsky, K., Owman, C. & Dlde, B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun. 303, 1047-1052 (2003).
26. Hirasawa, A., et al. Subtype-specific differences in subcellular localization of α1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface α1-adrenoceptors irrespective of the subtype. Mol. Pharmacol. 52, 764-770 (1997)
27. Awaji, T., et al. Real-time optical monitoring of ligand-mediated internalization of alpha1b-adrenoceptor with green fluorescent protein. Mol. Endocrinol. 12, 1099-1111 (1998).
28. Horie, K., Hirasawa, A. & Tsujimoto, G. The pharmacological profile of cloned and stably expressed alpha 1b-adrenoceptor in CHO cells. Eur. J. Pharmacol. 268, 399-407 (1994).
29. Awaji, T., Hirasawa, A., Shirakawa, H., Tsujimoto, G., Miyazaki, S. Novel green fluorescent protein-based ratiometric indicators for monitoring pH in defined intracellular microdomains. Biochem. Biophys. Res. Commun. 289, 457-462 (2001).
30. Gevrey, J.C., Cordier-Bussat, M., Nemoz-Gaillard, E., Chayvialle, J.A. & Abello, J. Co-requirement of cyclic AMP- and calcium-dependent protein kinases for transcriptional activation of cholecystokinin gene by protein hydrolysates. J. Biol. Chem. 277, 22407-22413 (2002).